20277 results for «»
20277 results
Prognostic implications of cardiac damage classification based on computed tomography in severe aortic stenosis
03 May 2021
In the PARTNER II trial, a new staging system of extra-aortic valvular cardiac damage is proposed, using 2 D transthoracic echocardiography and its prognostic value. The purpose of this study is to evaluate the prognostic value of such extra-aortic cardiac damage using MDCT in patients undergoing...
Reviewer
Reviewer
Mousa Akbar
Kuwait city, Kuwait
Alqoofi Faisal
Dhahran, Saudi Arabia
Mohamed Ayoub
Bad Oeynhausen, Germany
Jian Liu
Beijing, China
Farouk Mamdoo
South Africa
Xiantao Song
Beijing, China
Weixian Yang
Beijing, China
Next-generation TAVR device will enable lifetime management of aortic stenosis patients
18 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Reardon in order to learn more about supra-annular leaflet functioning in a balloon expandable TAVR device that enables commissural alignment, about 3D single-piece aortic valve design and how it contributes to improved TAVR durability, about the ADAPT tissue science and its proven resistance...
Efficient TAVI in the context of expanding indications?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Lars Sondergaard and Didier Tchetche in order to review latest data from the Evolut low-risk trial and the OptimizePro study, to learn more about latest TAVI patient pathway efficiency and economics evidence, and to discover how to translate these insights locally and enable you...
The power of Big Data: can a network meta-analysis reveal the true performance of a DES?
18 May 2021 – From EuroPCR 2021
Watch this session presented by Tullio Palmerini in order to learn about the recently published Network Meta-Analysis on TLF with current DES, to review the role of ultrathin DES in optimising clinical outcomes, and to assess the impact of the results on your daily practice.
Salem Assiri
We CARE: a joint initiative by PCR and Stent – Save a Life!
07 May 2021
Paris, France. Since the start of the COVID-19 pandemic, patients have been consistently deprived of timely cardiovascular treatment. This is due in part to measures taken in response to the sanitary crisis, but it is also due to patients' own unwillingness to seek medical help, even...
Novel Supreme DES with early synchronized antiproliferative drug delivery to inhibit smooth muscle cell proliferation after DES implantation in coronary artery disease: results of the PIONEER III randomized clinical trial
06 May 2021
The PIONEER III trial aims to assess the effectiveness and safety of the biodegradable-polymer sirolimus-eluting Supreme stent compared to durable-polymer everolimus-eluting stent (Xience or Promus), completely releasing the drug by 120 days.
Reviewer
Stefano Garzon
São Paulo, Brazil
José Mariani
Sao Paulo, Brazil
Guy Prado
Sao Paulo, Brazil
HIGHLIFE transseptal mitral valve replacement (TSMVR): clinical study update
18 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche in order to learn about the HighLife transseptal mitral valve replacement study status, to understand the complex patient population treated and first outcomes, and to be familiar with the current technology and future enhancements.
Deep vein and pulmonary interventions
In this session, observe right-sided ventricular failure due to Ebstein's anomaly, touch on large pulmonary arteriovenous malformation embolization, better master catheter thrombectomy to treat acute right iliofemoral DVT, and much more!
Left heart suffering after successful TAVI
12 May 2021 – From EuroPCR 2021
In this session, analyze a rare case of cardiogenic shock after TAVR, get prepared in case of Takotsubo cardiomyopathy after transcatheter aortic valve-in-valve replacement, get hints for troubleshooting in treating left-sided obstructions, find out more about transfemoral TAVI and mitral clipping for prevention of a SAM-phenomenon, and more!
